Dow Up 0.12% Nasdaq Up 1.35%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
31.92 0.91(2.93%) Oct 20, 4:00PM EDT
Prev Close:31.01
Open:30.86
Bid:27.50 x 100
Ask:36.10 x 2000
1y Target Est:60.60
Beta:-0.22
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:30.81 - 31.99
52wk Range:26.25 - 101.00
Volume:570,673
Avg Vol (3m):1,086,140
Market Cap:943.14M
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRUp 2.93%943.14M
AZN85.82B
MRK155.91B
PFE177.10B

Key Statistics

Forward P/E (1 yr):18.14
P/S (ttm):8.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.84
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback